Anavar 10mg

Oxandrolone 10mg, offer’s a mild yet effective oral anabolic that shines during cutting or recomp phases. Favoured by both men and women, Anavar 10mg promotes lean muscle, strength retention, and a polished look with minimal water retention.

Oxandrolone (Anavar 10mg) – Harm Reduction Crib Sheet

Compound: Oxandrolone (Anavar)
Class: Oral Anabolic-Androgenic Steroid (AAS), Dihydrotestosterone (DHT) derivative
Administration: Oral

Dosage

• Performance Use (Men): 30–60 mg/day
• Performance Use (Women): 5–15 mg/day
• Cycle Length: 4–6 weeks (8 weeks max with careful monitoring)

Half-Life

• ~9 to 10 hours
• Dosing frequency: 1–2 times daily for stable levels

Benefits

• Lean, dry muscle gains
• No aromatisation – no water retention or gynecomastia
• Mild on the liver (among 17α-alkylated orals)
• Enhances strength, vascularity, and muscle density
• Preserves muscle during calorie deficit
• Well tolerated by females at low doses

Side Effects

• Hepatotoxicity: Mild to moderate (still a 17α-alkylated oral)
• Androgenic: Acne, oily skin, hair thinning (rare at low/moderate doses)
• Suppression: Inhibits natural testosterone production in men
• Lipid impact: ↓ HDL, ↑ LDL
• Virilisation (women): Deepening of voice, facial hair, menstrual disruption if dose is too high or cycle is too long

Risks

• Liver strain: Elevated liver enzymes possible, especially at high doses or extended use
• Cardiovascular: Unfavourable lipid changes
• Endocrine: Suppression of HPTA in men; risk of virilisation in women
• Reproductive: Temporary infertility during use
• Psychological: Low incidence of mood-related effects

Risk Mitigation

• Bloodwork: Liver enzymes, lipids, TT/FT, CBC pre-, mid-, and post-cycle
• Cycle support: NAC (600–1200 mg/day), TUDCA if running high dose or >6 weeks
• Lipid support: Omega-3s, red yeast rice, fibre, regular cardio
• Testosterone base: Recommended for men to maintain libido, mood, and function
• Women: Use the lowest effective dose, discontinue at first signs of virilisation
• Avoid alcohol: Minimises hepatic strain
• Limit duration: 4–6 weeks typical; 8 weeks max if monitored

Post-Cycle Therapy (PCT)

For men not transitioning to TRT

• Start: 1–2 days after last dose
• Tamoxifen (Nolvadex):
  • 40 mg/day (Weeks 1–2)
  • 20 mg/day (Weeks 3–4)
• Optional – Clomiphene (Clomid): 50 mg/day for 4 weeks
• Follow-up labs: 4–6 weeks post-PCT

For women: PCT is not typically required, but bloodwork and hormonal monitoring are advised